{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:18Z","timestamp":1791932358111,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7574","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nature15395","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T11:39:40Z","timestamp":1444736380000},"page":"525-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":984,"title":["Mutations driving CLL and their evolution in progression and relapse"],"prefix":"10.1038","volume":"526","author":[{"given":"Dan A.","family":"Landau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaro N.","family":"Taylor-Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes G.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Bahlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"B\u00f6ttcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Cibulskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Sougnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian M.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Edelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kneba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ritgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Lander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"BFnature15395_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2012","unstructured":"Quesada, V. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nature Genet. 44, 47\u201352 (2012)","journal-title":"Nature Genet."},{"key":"BFnature15395_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101\u2013105 (2011)","journal-title":"Nature"},{"key":"BFnature15395_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714\u2013726 (2013)","journal-title":"Cell"},{"key":"BFnature15395_CR4","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1182\/blood-2012-05-433540","volume":"120","author":"A Schuh","year":"2012","unstructured":"Schuh, A. et al. Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns. Blood 120, 4191\u20134196 (2012)","journal-title":"Blood"},{"key":"BFnature15395_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495\u2013501 (2014)","journal-title":"Nature"},{"key":"BFnature15395_CR6","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","volume":"376","author":"M Hallek","year":"2010","unstructured":"Hallek, M. et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 376, 1164\u20131174 (2010)","journal-title":"Lancet"},{"key":"BFnature15395_CR7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013)","journal-title":"Nature"},{"key":"BFnature15395_CR8","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","volume":"120","author":"J Edelmann","year":"2012","unstructured":"Edelmann, J. et al. High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood 120, 4783\u20134794 (2012)","journal-title":"Blood"},{"key":"BFnature15395_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3109\/10428194.2012.723706","volume":"54","author":"L De Paoli","year":"2013","unstructured":"De Paoli, L. et al. MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia. Leuk. Lymphoma 54, 1087\u20131090 (2013)","journal-title":"Leuk. Lymphoma"},{"key":"BFnature15395_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/sj.onc.1208198","volume":"24","author":"I Schlosser","year":"2005","unstructured":"Schlosser, I. et al. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene 24, 520\u2013524 (2005)","journal-title":"Oncogene"},{"key":"BFnature15395_CR11","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3324\/haematol.2014.106401","volume":"99","author":"X Jiang","year":"2014","unstructured":"Jiang, X. et al. Critical role of SHP2 (PTPN11) signaling in germinal center-derived lymphoma. Haematologica 99, 1834\u20131845 (2014)","journal-title":"Haematologica"},{"key":"BFnature15395_CR12","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1038\/onc.2012.350","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang, J. & Chen, Q. M. Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene 32, 2907\u20132916 (2013)","journal-title":"Oncogene"},{"key":"BFnature15395_CR13","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci, E. et al. BRAF mutations in hairy-cell leukemia. N. Engl. J. Med. 364, 2305\u20132315 (2011)","journal-title":"N. Engl. J. Med."},{"key":"BFnature15395_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos, P. K. et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nature Genet. 46, 161\u2013165 (2014)","journal-title":"Nature Genet."},{"key":"BFnature15395_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cell.2009.12.040","volume":"140","author":"SJ Heidorn","year":"2010","unstructured":"Heidorn, S. J. et al. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell 140, 209\u2013221 (2010)","journal-title":"Cell"},{"key":"BFnature15395_CR16","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014)"},{"key":"BFnature15395_CR17","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1158\/0008-5472.CAN-10-0646","volume":"70","author":"H Yang","year":"2010","unstructured":"Yang, H. et al. RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. Cancer Res. 70, 5518\u20135527 (2010)","journal-title":"Cancer Res."},{"key":"BFnature15395_CR18","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3109\/10428194.2012.742525","volume":"54","author":"BM Jebaraj","year":"2013","unstructured":"Jebaraj, B. M. et al. BRAF mutations in chronic lymphocytic leukemia. Leuk. Lymphoma 54, 1177\u20131182 (2013)","journal-title":"Leuk. Lymphoma"},{"key":"BFnature15395_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/gm451","volume":"5","author":"DA Landau","year":"2013","unstructured":"Landau, D. A. & Wu, C. J. Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics. Genome Med. 5, 47 (2013)","journal-title":"Genome Med."},{"key":"BFnature15395_CR20","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1128\/MCB.01551-08","volume":"29","author":"G Sashida","year":"2009","unstructured":"Sashida, G. et al. ELF4\/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation. Mol. Cell. Biol. 29, 3687\u20133699 (2009)","journal-title":"Mol. Cell. Biol."},{"key":"BFnature15395_CR21","doi-asserted-by":"publisher","first-page":"31895","DOI":"10.1074\/jbc.M110.147520","volume":"285","author":"J Park","year":"2010","unstructured":"Park, J. et al. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. J. Biol. Chem. 285, 31895\u201331906 (2010)","journal-title":"J. Biol. Chem."},{"key":"BFnature15395_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ajhg.2008.11.004","volume":"83","author":"HT Gazda","year":"2008","unstructured":"Gazda, H. T. et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 83, 769\u2013780 (2008)","journal-title":"Am. J. Hum. Genet."},{"key":"BFnature15395_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1182\/blood-2012-08-450114","volume":"121","author":"I Ferreiros-Vidal","year":"2013","unstructured":"Ferreiros-Vidal, I. et al. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation. Blood 121, 1769\u20131782 (2013)","journal-title":"Blood"},{"key":"BFnature15395_CR24","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1182\/blood-2010-09-307140","volume":"117","author":"K Billot","year":"2011","unstructured":"Billot, K. et al. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications. Blood 117, 1917\u20131927 (2011)","journal-title":"Blood"},{"key":"BFnature15395_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1365-2141.2008.07442.x","volume":"144","author":"H N\u00fcckel","year":"2009","unstructured":"N\u00fcckel, H. et al. The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia. Br. J. Haematol. 144, 268\u2013270 (2009)","journal-title":"Br. J. Haematol."},{"key":"BFnature15395_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0002-9440(10)64256-3","volume":"161","author":"S Be\u00e0","year":"2002","unstructured":"Be\u00e0, S. et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter\u2019s syndrome). Am. J. Pathol. 161, 957\u2013968 (2002)","journal-title":"Am. J. Pathol."},{"key":"BFnature15395_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nature Biotechnol. 30, 413\u2013421 (2012)","journal-title":"Nature Biotechnol."},{"key":"BFnature15395_CR28","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616\u20133627 (2013)","journal-title":"Blood"},{"key":"BFnature15395_CR29","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. Elife 3, (2014)","DOI":"10.7554\/eLife.02869"},{"key":"BFnature15395_CR30","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","volume":"123","author":"S Stilgenbauer","year":"2014","unstructured":"Stilgenbauer, S. et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood 123, 3247\u20133254 (2014)","journal-title":"Blood"},{"key":"BFnature15395_CR31","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","volume":"121","author":"D Rossi","year":"2013","unstructured":"Rossi, D. et al. Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia. Blood 121, 1403\u20131412 (2013)","journal-title":"Blood"},{"key":"BFnature15395_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","volume":"4","author":"F Damm","year":"2014","unstructured":"Damm, F. et al. Acquired initiating mutations in early hematopoietic cells of CLL patients. Cancer Discov. 4, 1088\u20131101 (2014)","journal-title":"Cancer Discov."},{"key":"BFnature15395_CR33","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.3324\/haematol.2014.120238","volume":"100","author":"N Winkelmann","year":"2015","unstructured":"Winkelmann, N. et al. Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Haematologica 100, e237\u2013e239 (2015)","journal-title":"Haematologica"},{"key":"BFnature15395_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ng.2556","volume":"45","author":"XS Puente","year":"2013","unstructured":"Puente, X. S. & Lopez-Otin, C. The evolutionary biography of chronic lymphocytic leukemia. Nature Genet. 45, 229\u2013231 (2013)","journal-title":"Nature Genet."},{"key":"BFnature15395_CR35","doi-asserted-by":"publisher","first-page":"16226","DOI":"10.1073\/pnas.202617399","volume":"99","author":"MA Nowak","year":"2002","unstructured":"Nowak, M. A. et al. The role of chromosomal instability in tumor initiation. Proc. Natl Acad. Sci. USA 99, 16226\u201316231 (2002)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature15395_CR36","doi-asserted-by":"publisher","first-page":"18545","DOI":"10.1073\/pnas.1010978107","volume":"107","author":"I Bozic","year":"2010","unstructured":"Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl Acad. Sci. USA 107, 18545\u201318550 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature15395_CR37","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","volume":"155","author":"T Davoli","year":"2013","unstructured":"Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948\u2013962 (2013)","journal-title":"Cell"},{"key":"BFnature15395_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajh.23979","volume":"90","author":"M Hallek","year":"2015","unstructured":"Hallek, M. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Am. J. Hematol. 90, 446\u2013460 (2015)","journal-title":"Am. J. Hematol."},{"key":"BFnature15395_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013)","journal-title":"Nature"},{"key":"BFnature15395_CR40","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013)","journal-title":"Science"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature15395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature15395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature15395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:45:53Z","timestamp":1684417553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature15395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"7574","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnature15395"],"URL":"https:\/\/doi.org\/10.1038\/nature15395","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725850404.793538166","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"29 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B., S.S. and M.H. have received research support and honoraria from F. Hoffmann-La Roche. S.B. is a recipient of honoraria and research support from AbbVie and of research support from Celgene. All other authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}